US House Veterans' Affairs health subcommittee hears VA plans for psychedelic therapies ahead of possible FDA approval
Report from U.S. House Veterans’ Affairs subcommittee hearing on psychedelic-assisted therapies
The House Veterans' Affairs Subcommittee on Health held a hearing on psychedelic therapies for veterans, where VA senior advisor Andrew Gradison said the department has identified ten facilities as "early implementers" following FDAFDAThe Food and Drug Administration, the United States regulator of medicines, medical devices and food.Open the glossary approval. Gradison estimated roughly 180,000 veterans might be eligible, and researcher Mark Niciu said implementation could take months to years after approval, citing the REMS model for Spravato.
Key facts
- Kind of item
- Access and funding
- Condition
- PTSD
- Regulator
- FDA (United States)
- Jurisdiction
- United States
- Participants
- 180,000 veterans (as written in the text)
- Source
- The Microdose (UC Berkeley BCSP) (themicrodose.substack.com)
- Published
How this summary was made
The summary was written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method
Source: The Microdose (UC Berkeley BCSP) · themicrodose.substack.com
Connected to
- Kind of item
- Access and funding
- Condition
- PTSD
- Regulator
- FDA (United States)
- Jurisdiction
- United States